Previous 10 | Next 10 |
The following slide deck was published by Alcon Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Alcon Inc. 2021 Q1 - Results - Earnings Call Presentation
Alcon Inc. (ALC) Q1 2021 Results Conference Call May 05, 2021 08:00 AM ET Company Participants Karen King - Senior Vice President, Investor Relations and Communications David Endicott - Chief Executive Officer Tim Stonesifer - Senior Vice President and Chief Financial Officer Conference Call ...
Image source: The Motley Fool. Alcon Inc (NYSE: ALC) Q1 2021 Earnings Call May 5, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Alcon Inc (ALC) Q1 2021 Earnings Call Transcript
Esperion Therapeutics (ESPR) -32% on Q1 earnings release.Cocrystal Pharma (COCP) -27% after launches $40M stock offering.SemiLEDs (LEDS) -21%.Mercury Systems (MRCY) -18% on FQ3 earnings release.Adamis Pharmaceuticals (ADMP) -14%.Reed's (REED) -14% after...
Alcon (ALC) posted first-quarter results that beat Wall Street estimates, as new product launches helped drive market share gains despite the continued impacts of the COVID-19 pandemic.The company reported worldwide sales of $1.9B, beating analysts' average estimate of $1.86B.Surgic...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A rotation out of growth stocks into value on improving h...
Alcon (ALC) signed an agreement to acquire exclusive U.S. commercialization rights to Simbrinza 1%/0.2% from Novartis; Alcon will pay $355M on closure which is expected in Q2.The acquisition combined with its existing OTC eye drops will provide Alcon a strong ophthalmic eye dro...
Expands Alcon’s existing portfolio and strengthens position in the ophthalmic eye drops market Builds on company’s ophthalmic pharmaceutical manufacturing expertise Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see...
Innovative HydroBoost Technology offers long-lasting relief for patients with sensitive eyes or who use dry eye drops more than four times per day Latest formulation joins the fast-growing preservative-free segment of artificial tears Systane Hydration Multi-Dose P...
Alcon holds an upbeat capital markets day event, outlining its updated medium-term targets into 2025. A rich product pipeline and upcoming expansion plans underpin the growth and margin outlook. Meanwhile, the strong FCF generation is also set to continue, supporting its reinvestm...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...